1 not yet recruiting, 1 unknown. 2 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Not yet recruiting 1, Unknown 1 |
Follow Progression Free Survival: new trials by email Literature Review of Progression Free Survival trials Research Report on Progression Free Survival
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Sintilimab, Chidamide, and Azacitidine for Untreated Stage I-II Extranodal NK/T-Cell Lymphoma SCA Induction followed by Response-Adapted Therapy - Complete Remission Rateļ¼ CRR, Progression Free Survival | Not applicable | Not yet recruiting | Sun Yat-sen University | 30 | 2026-06-01 | 2026-04-21 |
| Id and Rd Maintenance Regimens After Induction of Remission in Multiple Myeloma. Ixazomib DX/Lenalidomide DX - Progression Free Survival, Overall Survival | Not applicable | Unknown | RenJi Hospital | 420 | 2023-02-16 | 2024-04-15 |
Lymphoma, Extranodal NK-T-Cell (1) · Multiple Myeloma (1)
Neoplasms (2) · Neoplasms by Histologic Type (2) · Blood Protein Disorders (1) · Cardiovascular Diseases (1) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Hemorrhagic Disorders (1) · Hemostatic Disorders (1) · Immune System Diseases (1) · Immunoproliferative Disorders (1) · Lymphoma (1) · Lymphoma, Non-Hodgkin (1) · Lymphoma, T-Cell (1) · Lymphoproliferative Disorders (1) · Neoplasms, Plasma Cell (1)
RenJi Hospital (1) · Sun Yat-sen University (1)
China (2)
Lu Zhong (1)